Deferasirox 125 mg, 250 mg, 500 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets for Oral Suspension
Available Strengths: 125 mg, 250 mg, 500 mg
Reference Brands: Exjade, Jadenu (film-coated)
Category: Anemia
Deferasirox treats transfusion-related iron overload. Available as Exjade and Jadenu in multiple strengths. Suitable for global pharma B2B supply.
Product Description:
Deferasirox is a leading oral iron chelation therapy used to manage chronic iron overload in patients receiving long-term blood transfusions, such as those with thalassemia or sickle cell disease. It is available as 125 mg, 250 mg, and 500 mg tablets for oral suspension, and 90 mg, 180 mg, and 360 mg film-coated tablets (Jadenu®). Trusted brands like Exjade and Jadenu are approved in the US and EU. Deferasirox is manufactured in GMP-certified facilities and is ideal for pharma B2B distribution, including hospitals, clinics, and global buyers. Contact us for bulk export and regulatory support.
Deferasirox — third party manufacturing & bulk supply
Deferasirox 125 mg, 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Deferasirox is supplied as Tablets for Oral Suspension — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Deferasirox listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Deferasirox →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Deferasirox is used for treating chronic iron overload in patients who require frequent blood transfusions, such as those with thalassemia or sickle cell disease.
Deferasirox is made from the active ingredient deferasirox along with inactive excipients depending on whether it is a dispersible tablet or film-coated tablet.
The trade names are Exjade and Jadenu.
Deferasirox (Exjade and Jadenu) is manufactured by Novartis Pharmaceuticals.
The generic name is deferasirox.
The brand names are Exjade and Jadenu.
Deferasirox is manufactured by Novartis in approved facilities located in the USA and Europe.
Related Products
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
